Company intelligence / Profile preview

四川贝灵合益制药

Chengdu, Sichuan, China

Ownership: Private
Development stage: Other

Overview

Sichuan Beiling Heyi Pharmaceutical is a specialized pharmaceutical company located in Chengdu, China, focused on the industrialization of biotechnology innovations. The company is a key entity within the Beiling group, which is recognized for its expertise in recombinant humanized collagen technology. Beiling Heyi manages the manufacturing and pharmaceutical development aspects of the group's portfolio, targeting applications in regenerative medicine, dermatology, and medical aesthetics. By integrating high-tech R&D with GMP-compliant production, the company provides advanced therapeutic solutions for tissue repair and skin health.

Therapeutic areas: Dermatology
Modalities: Recombinant proteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on 四川贝灵合益制药.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 四川贝灵合益制药.

Explore the full profile